Graves' ophthalmopathy: a preventable disease?

被引:50
作者
Bartalena, L
Marcocci, C
Pinchera, A
机构
[1] Univ Insubria, Cattedra Endocrinol, I-21100 Varese, Italy
[2] Univ Pisa, Dipartimento Endocrinol, Pisa, Italy
关键词
D O I
10.1530/eje.0.1460457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most patients with Graves' disease have some degree of ocular involvement, but only 3-5% of them develop severe ophthalmopathy (1). The reasons why only such a minority of patients with Graves' disease have severe expression of the ophthalmopathy remain to be elucidated. One possible explanation is that non-severe ophthalmopathy and severe ophthalmopathy are two different disorders with different genetic backgrounds; alternatively, they might be part of a spectrum of different conditions ranging from absent ocular involvement to most severe ophthalmopathy. In this case, external variables (i.e. environmental factors) must contribute to the nature of the expression of the disease. How important are they? How far can our intervention on environmental factors go towards reducing the risk of progression of the ophthalmopathy? In other words, to which extent, if any, is Graves' ophthalmopathy preventable? The aim of this mini-review is to address the above issues.
引用
收藏
页码:457 / 461
页数:5
相关论文
共 37 条
[1]   Management of Graves' ophthalmopathy: Reality and perspectives [J].
Bartalena, L ;
Pinchera, A ;
Marcocci, C .
ENDOCRINE REVIEWS, 2000, 21 (02) :168-199
[2]   MORE ON SMOKING-HABITS AND GRAVES OPHTHALMOPATHY [J].
BARTALENA, L ;
MARTINO, E ;
MARCOCCI, C ;
BOGAZZI, F ;
PANICUCCI, M ;
VELLUZZI, F ;
LOVISELLI, A ;
PINCHERA, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1989, 12 (10) :733-737
[3]   Cigarette smoking and treatment outcomes in Graves ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Tanda, ML ;
Manetti, L ;
Dell'Unto, E ;
Bartolomei, MP ;
Nardi, M ;
Martino, E ;
Pinchera, A .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (08) :632-635
[4]   CIGARETTE-SMOKING AND THE THYROID [J].
BARTALENA, L ;
BOGAZZI, F ;
TANDA, ML ;
MANETTI, L ;
DELLUNTO, E ;
MARTINO, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (05) :507-512
[5]   Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Bogazzi, F ;
Manetti, L ;
Tanda, ML ;
Dell'Unto, E ;
Bruno-Bossio, G ;
Nardi, M ;
Bartolomei, MP ;
Lepri, A ;
Rossi, G ;
Martino, E ;
Pinchera, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78
[6]   USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].
BARTALENA, L ;
MARCOCCI, C ;
BOGAZZI, F ;
PANICUCCI, M ;
LEPRI, A ;
PINCHERA, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352
[7]  
BARTALENA L, 2000, GRAVES DIS PATHOGENE, P279
[8]  
Bartley G B, 1994, Trans Am Ophthalmol Soc, V92, P477
[9]   COMPARISON OF RA I-131 TREATMENT PROTOCOLS FOR GRAVES-DISEASE [J].
DEGROOT, LJ ;
MANGKLABRUKS, A ;
MCCORMICK, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1990, 13 (02) :111-118
[10]  
DeGroot LJ, 1996, ORBIT-ABINGDON, V15, P187